Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-08-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于监事辞职及补选监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor and the election of a new supervisor. It includes details about the resignation, the reason, the replacement, and the qualifications of the new supervisor. There are no financial statements, earnings data, or detailed financial analysis. The content focuses on changes in the company's supervisory board, which falls under management or board changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a certification, so it is not a Regulatory Filing or Report Publication Announcement.
2021-08-26 Chinese
关于海尔集团财务有限责任公司2021年半年度风险评估报告
Interim / Quarterly Report Classification · 95% confidence The document is a detailed risk assessment report for the first half of 2021 regarding a financial company affiliated with Haier Group, prepared by Yingkang Life Technology Co., Ltd. It includes financial data as of June 30, 2021, internal control evaluations, risk management practices, and compliance with regulatory requirements. The content is comprehensive and includes substantive financial data and analysis for a half-year period. The document length is 4434 characters, which is relatively short but contains detailed financial and risk management information, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR) rather than a brief announcement or regulatory filing. H1 2021
2021-08-26 Chinese
独立董事关于第五届董事会第十二次会议相关事项的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent directors' opinion on several matters discussed at the company's fifth board of directors' twelfth meeting. It includes independent opinions on a mid-year risk assessment report, a mid-year special report on the use of raised funds, cash management of idle funds, appointment of the general manager, and related party transactions and guarantees for the half-year period of 2021. The document references regulatory guidelines and compliance with laws and company articles. It is not a full financial report but rather an independent opinion or audit-related commentary on specific reports and corporate governance matters. The document length is about 2000 characters, which is relatively short and focused on independent directors' opinions rather than full financial statements or comprehensive management discussion. This fits best with an Audit Report / Information (AR) category, as it is a standalone audit-related opinion document on specific financial and governance matters, not a full annual or interim report, nor a simple announcement or certification. Therefore, the classification is AR with high confidence. H1 2021
2021-08-26 Chinese
关于公司董事、高级管理人员变动的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board of directors and senior management, specifically the resignation of the general manager and appointment of a new general manager and legal representative. It includes details about the individuals involved, their qualifications, and compliance with relevant laws. There is no financial data or report content, and the document is focused on management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2021-08-26 Chinese
关于2021年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "专项报告" (special report) on the half-year (2021) status of raised funds' deposit and usage by 盈康生命科技股份有限公司. It details the amount of funds raised, their deposit, usage, management, and compliance with regulatory requirements. The document references regulatory guidelines on the management and use of raised funds and includes detailed financial figures related to fundraising and usage during the half-year period ending June 30, 2021. This type of report is a specialized disclosure on fundraising activities and usage, not a full annual or interim financial report, nor an earnings release or management discussion. It fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is about 4952 characters, which is sufficient for a detailed report rather than a mere announcement. Therefore, the classification is CAP with high confidence.
2021-08-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding the approval of the company's 2021 semi-annual report and related matters. It includes voting results and confirms the review of the 2021 semi-annual report and other financial usage reports. The document does not contain the actual semi-annual financial statements or detailed financial data but refers to the full report being disclosed elsewhere (on 巨潮资讯网). The document is short (1436 characters) and serves as an official announcement of the Supervisory Board's meeting decisions and approvals rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a formal announcement of supervisory board resolutions and approvals related to the interim report, not the interim report itself.
2021-08-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.